- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to our latest study, the global Transdermal Drug Patches market size was valued at USD 7028.9 million in 2022 and is forecast to a readjusted size of USD 7952.9 million by 2029 with a CAGR of 1.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of transdermal drug patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, etc. The top five players hold a share about 37%. North America is the largest market, has a share about 50%, followed by Europe and Asia-Pacific, both have a share about 24 percent.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
This report is a detailed and comprehensive analysis for global Transdermal Drug Patches market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Transdermal Drug Patches market size and forecasts, in consumption value ($ Million), sales quantity (M Pieces), and average selling prices (USD/Piece), 2018-2029
Global Transdermal Drug Patches market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Pieces), and average selling prices (USD/Piece), 2018-2029
Global Transdermal Drug Patches market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Pieces), and average selling prices (USD/Piece), 2018-2029
Global Transdermal Drug Patches market shares of main players, shipments in revenue ($ Million), sales quantity (M Pieces), and ASP (USD/Piece), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transdermal Drug Patches
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transdermal Drug Patches market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Transdermal Drug Patches market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Market segment by Application
Rx Channel
OTC Channel
Major players covered
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy’s Laboratories
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Drug Patches product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Transdermal Drug Patches, with price, sales, revenue and global market share of Transdermal Drug Patches from 2018 to 2023.
Chapter 3, the Transdermal Drug Patches competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Drug Patches breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Transdermal Drug Patches market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Transdermal Drug Patches.
Chapter 14 and 15, to describe Transdermal Drug Patches sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Transdermal Drug Patches
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Transdermal Drug Patches Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Methyl Salicylate-based Patch
1.3.3 Rivastigmine Transdermal Patch
1.3.4 Fentanyl Transdermal Patch
1.3.5 Lidocaine Patch
1.3.6 Diclofenac Patch
1.3.7 Nicotine Transdermal Patch
1.3.8 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Transdermal Drug Patches Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Rx Channel
1.4.3 OTC Channel
1.5 Global Transdermal Drug Patches Market Size & Forecast
1.5.1 Global Transdermal Drug Patches Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Transdermal Drug Patches Sales Quantity (2018-2029)
1.5.3 Global Transdermal Drug Patches Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Hisamitsu Pharmaceutical
2.1.1 Hisamitsu Pharmaceutical Details
2.1.2 Hisamitsu Pharmaceutical Major Business
2.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Product and Services
2.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Transdermal Drug Patches Product and Services
2.2.4 Johnson & Johnson Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Transdermal Drug Patches Product and Services
2.3.4 Mylan Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Mylan Recent Developments/Updates
2.4 UCB Pharma
2.4.1 UCB Pharma Details
2.4.2 UCB Pharma Major Business
2.4.3 UCB Pharma Transdermal Drug Patches Product and Services
2.4.4 UCB Pharma Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 UCB Pharma Recent Developments/Updates
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Transdermal Drug Patches Product and Services
2.5.4 Novartis Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novartis Recent Developments/Updates
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business
2.6.3 Teva Pharmaceutical Transdermal Drug Patches Product and Services
2.6.4 Teva Pharmaceutical Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Pharmaceutical Recent Developments/Updates
2.7 Beijing Tide Pharmaceutical
2.7.1 Beijing Tide Pharmaceutical Details
2.7.2 Beijing Tide Pharmaceutical Major Business
2.7.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Product and Services
2.7.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Beijing Tide Pharmaceutical Recent Developments/Updates
2.8 Chattem
2.8.1 Chattem Details
2.8.2 Chattem Major Business
2.8.3 Chattem Transdermal Drug Patches Product and Services
2.8.4 Chattem Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Chattem Recent Developments/Updates
2.9 Nitto Denko
2.9.1 Nitto Denko Details
2.9.2 Nitto Denko Major Business
2.9.3 Nitto Denko Transdermal Drug Patches Product and Services
2.9.4 Nitto Denko Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Nitto Denko Recent Developments/Updates
2.10 Grünenthal
2.10.1 Grünenthal Details
2.10.2 Grünenthal Major Business
2.10.3 Grünenthal Transdermal Drug Patches Product and Services
2.10.4 Grünenthal Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Grünenthal Recent Developments/Updates
2.11 Mundipharma
2.11.1 Mundipharma Details
2.11.2 Mundipharma Major Business
2.11.3 Mundipharma Transdermal Drug Patches Product and Services
2.11.4 Mundipharma Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Mundipharma Recent Developments/Updates
2.12 GSK
2.12.1 GSK Details
2.12.2 GSK Major Business
2.12.3 GSK Transdermal Drug Patches Product and Services
2.12.4 GSK Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 GSK Recent Developments/Updates
2.13 Luye Pharma Group
2.13.1 Luye Pharma Group Details
2.13.2 Luye Pharma Group Major Business
2.13.3 Luye Pharma Group Transdermal Drug Patches Product and Services
2.13.4 Luye Pharma Group Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Luye Pharma Group Recent Developments/Updates
2.14 Bayer
2.14.1 Bayer Details
2.14.2 Bayer Major Business
2.14.3 Bayer Transdermal Drug Patches Product and Services
2.14.4 Bayer Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Bayer Recent Developments/Updates
2.15 IBSA Group
2.15.1 IBSA Group Details
2.15.2 IBSA Group Major Business
2.15.3 IBSA Group Transdermal Drug Patches Product and Services
2.15.4 IBSA Group Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 IBSA Group Recent Developments/Updates
2.16 Dr Reddy’s Laboratories
2.16.1 Dr Reddy’s Laboratories Details
2.16.2 Dr Reddy’s Laboratories Major Business
2.16.3 Dr Reddy’s Laboratories Transdermal Drug Patches Product and Services
2.16.4 Dr Reddy’s Laboratories Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Dr Reddy’s Laboratories Recent Developments/Updates
3 Competitive Environment: Transdermal Drug Patches by Manufacturer
3.1 Global Transdermal Drug Patches Sales Quantity by Manufacturer (2018-2023)
3.2 Global Transdermal Drug Patches Revenue by Manufacturer (2018-2023)
3.3 Global Transdermal Drug Patches Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Transdermal Drug Patches by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Transdermal Drug Patches Manufacturer Market Share in 2022
3.4.2 Top 6 Transdermal Drug Patches Manufacturer Market Share in 2022
3.5 Transdermal Drug Patches Market: Overall Company Footprint Analysis
3.5.1 Transdermal Drug Patches Market: Region Footprint
3.5.2 Transdermal Drug Patches Market: Company Product Type Footprint
3.5.3 Transdermal Drug Patches Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Transdermal Drug Patches Market Size by Region
4.1.1 Global Transdermal Drug Patches Sales Quantity by Region (2018-2029)
4.1.2 Global Transdermal Drug Patches Consumption Value by Region (2018-2029)
4.1.3 Global Transdermal Drug Patches Average Price by Region (2018-2029)
4.2 North America Transdermal Drug Patches Consumption Value (2018-2029)
4.3 Europe Transdermal Drug Patches Consumption Value (2018-2029)
4.4 Asia-Pacific Transdermal Drug Patches Consumption Value (2018-2029)
4.5 South America Transdermal Drug Patches Consumption Value (2018-2029)
4.6 Middle East and Africa Transdermal Drug Patches Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Transdermal Drug Patches Sales Quantity by Type (2018-2029)
5.2 Global Transdermal Drug Patches Consumption Value by Type (2018-2029)
5.3 Global Transdermal Drug Patches Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Transdermal Drug Patches Sales Quantity by Application (2018-2029)
6.2 Global Transdermal Drug Patches Consumption Value by Application (2018-2029)
6.3 Global Transdermal Drug Patches Average Price by Application (2018-2029)
7 North America
7.1 North America Transdermal Drug Patches Sales Quantity by Type (2018-2029)
7.2 North America Transdermal Drug Patches Sales Quantity by Application (2018-2029)
7.3 North America Transdermal Drug Patches Market Size by Country
7.3.1 North America Transdermal Drug Patches Sales Quantity by Country (2018-2029)
7.3.2 North America Transdermal Drug Patches Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Transdermal Drug Patches Sales Quantity by Type (2018-2029)
8.2 Europe Transdermal Drug Patches Sales Quantity by Application (2018-2029)
8.3 Europe Transdermal Drug Patches Market Size by Country
8.3.1 Europe Transdermal Drug Patches Sales Quantity by Country (2018-2029)
8.3.2 Europe Transdermal Drug Patches Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Transdermal Drug Patches Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Transdermal Drug Patches Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Transdermal Drug Patches Market Size by Region
9.3.1 Asia-Pacific Transdermal Drug Patches Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Transdermal Drug Patches Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Transdermal Drug Patches Sales Quantity by Type (2018-2029)
10.2 South America Transdermal Drug Patches Sales Quantity by Application (2018-2029)
10.3 South America Transdermal Drug Patches Market Size by Country
10.3.1 South America Transdermal Drug Patches Sales Quantity by Country (2018-2029)
10.3.2 South America Transdermal Drug Patches Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Transdermal Drug Patches Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Transdermal Drug Patches Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Transdermal Drug Patches Market Size by Country
11.3.1 Middle East & Africa Transdermal Drug Patches Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Transdermal Drug Patches Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Transdermal Drug Patches Market Drivers
12.2 Transdermal Drug Patches Market Restraints
12.3 Transdermal Drug Patches Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Transdermal Drug Patches and Key Manufacturers
13.2 Manufacturing Costs Percentage of Transdermal Drug Patches
13.3 Transdermal Drug Patches Production Process
13.4 Transdermal Drug Patches Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Transdermal Drug Patches Typical Distributors
14.3 Transdermal Drug Patches Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Transdermal Drug Patches Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Transdermal Drug Patches Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Hisamitsu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Hisamitsu Pharmaceutical Major Business
Table 5. Hisamitsu Pharmaceutical Transdermal Drug Patches Product and Services
Table 6. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson & Johnson Major Business
Table 10. Johnson & Johnson Transdermal Drug Patches Product and Services
Table 11. Johnson & Johnson Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Johnson & Johnson Recent Developments/Updates
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Major Business
Table 15. Mylan Transdermal Drug Patches Product and Services
Table 16. Mylan Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Mylan Recent Developments/Updates
Table 18. UCB Pharma Basic Information, Manufacturing Base and Competitors
Table 19. UCB Pharma Major Business
Table 20. UCB Pharma Transdermal Drug Patches Product and Services
Table 21. UCB Pharma Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. UCB Pharma Recent Developments/Updates
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Transdermal Drug Patches Product and Services
Table 26. Novartis Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Novartis Recent Developments/Updates
Table 28. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Teva Pharmaceutical Major Business
Table 30. Teva Pharmaceutical Transdermal Drug Patches Product and Services
Table 31. Teva Pharmaceutical Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Teva Pharmaceutical Recent Developments/Updates
Table 33. Beijing Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Beijing Tide Pharmaceutical Major Business
Table 35. Beijing Tide Pharmaceutical Transdermal Drug Patches Product and Services
Table 36. Beijing Tide Pharmaceutical Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 38. Chattem Basic Information, Manufacturing Base and Competitors
Table 39. Chattem Major Business
Table 40. Chattem Transdermal Drug Patches Product and Services
Table 41. Chattem Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Chattem Recent Developments/Updates
Table 43. Nitto Denko Basic Information, Manufacturing Base and Competitors
Table 44. Nitto Denko Major Business
Table 45. Nitto Denko Transdermal Drug Patches Product and Services
Table 46. Nitto Denko Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Nitto Denko Recent Developments/Updates
Table 48. Grünenthal Basic Information, Manufacturing Base and Competitors
Table 49. Grünenthal Major Business
Table 50. Grünenthal Transdermal Drug Patches Product and Services
Table 51. Grünenthal Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Grünenthal Recent Developments/Updates
Table 53. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 54. Mundipharma Major Business
Table 55. Mundipharma Transdermal Drug Patches Product and Services
Table 56. Mundipharma Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Mundipharma Recent Developments/Updates
Table 58. GSK Basic Information, Manufacturing Base and Competitors
Table 59. GSK Major Business
Table 60. GSK Transdermal Drug Patches Product and Services
Table 61. GSK Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. GSK Recent Developments/Updates
Table 63. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 64. Luye Pharma Group Major Business
Table 65. Luye Pharma Group Transdermal Drug Patches Product and Services
Table 66. Luye Pharma Group Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Luye Pharma Group Recent Developments/Updates
Table 68. Bayer Basic Information, Manufacturing Base and Competitors
Table 69. Bayer Major Business
Table 70. Bayer Transdermal Drug Patches Product and Services
Table 71. Bayer Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Bayer Recent Developments/Updates
Table 73. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 74. IBSA Group Major Business
Table 75. IBSA Group Transdermal Drug Patches Product and Services
Table 76. IBSA Group Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. IBSA Group Recent Developments/Updates
Table 78. Dr Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 79. Dr Reddy’s Laboratories Major Business
Table 80. Dr Reddy’s Laboratories Transdermal Drug Patches Product and Services
Table 81. Dr Reddy’s Laboratories Transdermal Drug Patches Sales Quantity (M Pieces), Average Price (USD/Piece), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Dr Reddy’s Laboratories Recent Developments/Updates
Table 83. Global Transdermal Drug Patches Sales Quantity by Manufacturer (2018-2023) & (M Pieces)
Table 84. Global Transdermal Drug Patches Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Transdermal Drug Patches Average Price by Manufacturer (2018-2023) & (USD/Piece)
Table 86. Market Position of Manufacturers in Transdermal Drug Patches, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Transdermal Drug Patches Production Site of Key Manufacturer
Table 88. Transdermal Drug Patches Market: Company Product Type Footprint
Table 89. Transdermal Drug Patches Market: Company Product Application Footprint
Table 90. Transdermal Drug Patches New Market Entrants and Barriers to Market Entry
Table 91. Transdermal Drug Patches Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Transdermal Drug Patches Sales Quantity by Region (2018-2023) & (M Pieces)
Table 93. Global Transdermal Drug Patches Sales Quantity by Region (2024-2029) & (M Pieces)
Table 94. Global Transdermal Drug Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Transdermal Drug Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Transdermal Drug Patches Average Price by Region (2018-2023) & (USD/Piece)
Table 97. Global Transdermal Drug Patches Average Price by Region (2024-2029) & (USD/Piece)
Table 98. Global Transdermal Drug Patches Sales Quantity by Type (2018-2023) & (M Pieces)
Table 99. Global Transdermal Drug Patches Sales Quantity by Type (2024-2029) & (M Pieces)
Table 100. Global Transdermal Drug Patches Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Transdermal Drug Patches Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Transdermal Drug Patches Average Price by Type (2018-2023) & (USD/Piece)
Table 103. Global Transdermal Drug Patches Average Price by Type (2024-2029) & (USD/Piece)
Table 104. Global Transdermal Drug Patches Sales Quantity by Application (2018-2023) & (M Pieces)
Table 105. Global Transdermal Drug Patches Sales Quantity by Application (2024-2029) & (M Pieces)
Table 106. Global Transdermal Drug Patches Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Transdermal Drug Patches Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Transdermal Drug Patches Average Price by Application (2018-2023) & (USD/Piece)
Table 109. Global Transdermal Drug Patches Average Price by Application (2024-2029) & (USD/Piece)
Table 110. North America Transdermal Drug Patches Sales Quantity by Type (2018-2023) & (M Pieces)
Table 111. North America Transdermal Drug Patches Sales Quantity by Type (2024-2029) & (M Pieces)
Table 112. North America Transdermal Drug Patches Sales Quantity by Application (2018-2023) & (M Pieces)
Table 113. North America Transdermal Drug Patches Sales Quantity by Application (2024-2029) & (M Pieces)
Table 114. North America Transdermal Drug Patches Sales Quantity by Country (2018-2023) & (M Pieces)
Table 115. North America Transdermal Drug Patches Sales Quantity by Country (2024-2029) & (M Pieces)
Table 116. North America Transdermal Drug Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Transdermal Drug Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Transdermal Drug Patches Sales Quantity by Type (2018-2023) & (M Pieces)
Table 119. Europe Transdermal Drug Patches Sales Quantity by Type (2024-2029) & (M Pieces)
Table 120. Europe Transdermal Drug Patches Sales Quantity by Application (2018-2023) & (M Pieces)
Table 121. Europe Transdermal Drug Patches Sales Quantity by Application (2024-2029) & (M Pieces)
Table 122. Europe Transdermal Drug Patches Sales Quantity by Country (2018-2023) & (M Pieces)
Table 123. Europe Transdermal Drug Patches Sales Quantity by Country (2024-2029) & (M Pieces)
Table 124. Europe Transdermal Drug Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Transdermal Drug Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Transdermal Drug Patches Sales Quantity by Type (2018-2023) & (M Pieces)
Table 127. Asia-Pacific Transdermal Drug Patches Sales Quantity by Type (2024-2029) & (M Pieces)
Table 128. Asia-Pacific Transdermal Drug Patches Sales Quantity by Application (2018-2023) & (M Pieces)
Table 129. Asia-Pacific Transdermal Drug Patches Sales Quantity by Application (2024-2029) & (M Pieces)
Table 130. Asia-Pacific Transdermal Drug Patches Sales Quantity by Region (2018-2023) & (M Pieces)
Table 131. Asia-Pacific Transdermal Drug Patches Sales Quantity by Region (2024-2029) & (M Pieces)
Table 132. Asia-Pacific Transdermal Drug Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Transdermal Drug Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Transdermal Drug Patches Sales Quantity by Type (2018-2023) & (M Pieces)
Table 135. South America Transdermal Drug Patches Sales Quantity by Type (2024-2029) & (M Pieces)
Table 136. South America Transdermal Drug Patches Sales Quantity by Application (2018-2023) & (M Pieces)
Table 137. South America Transdermal Drug Patches Sales Quantity by Application (2024-2029) & (M Pieces)
Table 138. South America Transdermal Drug Patches Sales Quantity by Country (2018-2023) & (M Pieces)
Table 139. South America Transdermal Drug Patches Sales Quantity by Country (2024-2029) & (M Pieces)
Table 140. South America Transdermal Drug Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Transdermal Drug Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Transdermal Drug Patches Sales Quantity by Type (2018-2023) & (M Pieces)
Table 143. Middle East & Africa Transdermal Drug Patches Sales Quantity by Type (2024-2029) & (M Pieces)
Table 144. Middle East & Africa Transdermal Drug Patches Sales Quantity by Application (2018-2023) & (M Pieces)
Table 145. Middle East & Africa Transdermal Drug Patches Sales Quantity by Application (2024-2029) & (M Pieces)
Table 146. Middle East & Africa Transdermal Drug Patches Sales Quantity by Region (2018-2023) & (M Pieces)
Table 147. Middle East & Africa Transdermal Drug Patches Sales Quantity by Region (2024-2029) & (M Pieces)
Table 148. Middle East & Africa Transdermal Drug Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Transdermal Drug Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Transdermal Drug Patches Raw Material
Table 151. Key Manufacturers of Transdermal Drug Patches Raw Materials
Table 152. Transdermal Drug Patches Typical Distributors
Table 153. Transdermal Drug Patches Typical Customers
List of Figures
Figure 1. Transdermal Drug Patches Picture
Figure 2. Global Transdermal Drug Patches Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Transdermal Drug Patches Consumption Value Market Share by Type in 2022
Figure 4. Methyl Salicylate-based Patch Examples
Figure 5. Rivastigmine Transdermal Patch Examples
Figure 6. Fentanyl Transdermal Patch Examples
Figure 7. Lidocaine Patch Examples
Figure 8. Diclofenac Patch Examples
Figure 9. Nicotine Transdermal Patch Examples
Figure 10. Others Examples
Figure 11. Global Transdermal Drug Patches Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 12. Global Transdermal Drug Patches Consumption Value Market Share by Application in 2022
Figure 13. Rx Channel Examples
Figure 14. OTC Channel Examples
Figure 15. Global Transdermal Drug Patches Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Transdermal Drug Patches Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Transdermal Drug Patches Sales Quantity (2018-2029) & (M Pieces)
Figure 18. Global Transdermal Drug Patches Average Price (2018-2029) & (USD/Piece)
Figure 19. Global Transdermal Drug Patches Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Transdermal Drug Patches Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Transdermal Drug Patches by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Transdermal Drug Patches Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Transdermal Drug Patches Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Transdermal Drug Patches Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Transdermal Drug Patches Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Transdermal Drug Patches Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Transdermal Drug Patches Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Transdermal Drug Patches Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Transdermal Drug Patches Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Transdermal Drug Patches Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Transdermal Drug Patches Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Transdermal Drug Patches Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Transdermal Drug Patches Average Price by Type (2018-2029) & (USD/Piece)
Figure 34. Global Transdermal Drug Patches Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Transdermal Drug Patches Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Transdermal Drug Patches Average Price by Application (2018-2029) & (USD/Piece)
Figure 37. North America Transdermal Drug Patches Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Transdermal Drug Patches Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Transdermal Drug Patches Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Transdermal Drug Patches Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Transdermal Drug Patches Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Transdermal Drug Patches Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Transdermal Drug Patches Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Transdermal Drug Patches Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Transdermal Drug Patches Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Transdermal Drug Patches Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Transdermal Drug Patches Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Transdermal Drug Patches Consumption Value Market Share by Region (2018-2029)
Figure 57. China Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Transdermal Drug Patches Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Transdermal Drug Patches Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Transdermal Drug Patches Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Transdermal Drug Patches Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Transdermal Drug Patches Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Transdermal Drug Patches Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Transdermal Drug Patches Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Transdermal Drug Patches Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Transdermal Drug Patches Market Drivers
Figure 78. Transdermal Drug Patches Market Restraints
Figure 79. Transdermal Drug Patches Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Transdermal Drug Patches in 2022
Figure 82. Manufacturing Process Analysis of Transdermal Drug Patches
Figure 83. Transdermal Drug Patches Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
